ProShares Ultra CRCL (CRCA) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 149 252 sessions, November 5, 2025 to November 5, 2026
- Largest daily move
- +70.2% close of February 25, 2026
- 1-year change
- -88.1% closing prices, November 5, 2025 to November 5, 2026
- 1-month change
- -35.2% closing prices, October 5, 2026 to November 5, 2026
Company Description
ProShares Ultra CRCL (CRCA) is an exchange-traded fund offered by ProShares, an ETF sponsor known for geared strategies, including leveraged and inverse ETF investing. The fund is part of a ProShares lineup that includes products tied to dividend growth, high income, interest-rate-hedged bonds, crypto exposure, and tactical ETF strategies.
As a ProShares ETF, ProShares Ultra CRCL is associated with fund-level mechanics and risks typical of the sponsor's geared products. ProShares materials describe its ETFs as generally non-diversified and note that certain funds may use derivatives such as swap agreements, futures contracts, and similar instruments. These instruments, along with leverage, imperfect benchmark correlation, and market price variance, can increase volatility and affect fund performance.
Recent ProShares fund communications also address ETF share actions such as reverse share splits. A reverse split changes the number of shares outstanding and the per-share trading price but does not, by itself, change the total value of a shareholder's investment. CRCA's public-company profile is therefore best understood as a fund reference record tied to ProShares' ETF platform rather than as an operating business with products, customers, or operating segments.
Stock Performance
ProShares Ultra CRCL (CRCA) closed at $11.52 on November 5, 2026. Over the past 12 months, the price has lost 88.1%.
CRCA Metrics & Rankings
Price returns through November 5, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
ProShares Ultra CRCL has 2 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. View all CRCA news →
SEC Filings
Short Interest History
Short interest in ProShares Ultra CRCL (CRCA) currently stands at 1.2 million shares, down 8.5% from the previous reporting period, representing 21.3% of the shares outstanding. Since the latest stock split, short interest has increased by 2695.0%, measured from March 2026.
Days to Cover History
Days to cover for ProShares Ultra CRCL (CRCA) currently stands at 2.6 days, up 42.9% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has increased by 163%. Across the settlements charted above, it has ranged from 1.0 to 2.6 days.